Market Cap (In JPY)
30.96 Billion
Revenue (In JPY)
46.89 Billion
Net Income (In JPY)
3.29 Billion
Avg. Volume
49.43 Thousand
- Currency
- JPY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1803.0-2573.0
- PE
- -
- EPS
- -
- Beta Value
- 0.27
- ISIN
- JP3486150000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hiroshi Matsumori
- Employee Count
- -
- Website
- https://www.daitonet.co.jp
- Ipo Date
- 2010-03-24
- Details
- Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
More Stocks
-
6237Iwaki Co., Ltd.
6237
-
SPHProfithol, S.A.
SPH
-
NAVINFLUORNavin Fluorine International Limited
NAVINFLUOR
-
6470
-
TARS
-
DBOEYDeutsche Börse AG
DBOEY
-
ZDPY
-
5257Nova System Co.,Ltd.
5257